This website uses cookies so that we can provide you with the best user experience possible. Our Cookie Notice is part of our Privacy Policy and explains in detail how and why we use cookies. To take full advantage of our website, we recommend that you click on “Accept All”. You can change these settings at any time via the button "Update Cookie Preferences" in our Cookie Notice.
Technical cookies are required for the site to function properly, to be legally compliant and secure. Session cookies only last for the duration of your visit and are deleted from your device when you close your internet browser. Persistent cookies, however, remain and continue functioning on repeat visits.
CMS does not use any cookie based Analytics or tracking on our websites; see details here.
Personalisation cookies collect information about your website browsing habits and offer you a personalised user experience based on past visits, your location or browser settings. They also allow you to log in to personalised areas and to access third party tools that may be embedded in our website. Some functionality will not work if you don’t accept these cookies.
27/06/2014
CMS Bureau Francis Lefebvre advises Cegedim in connection with the carving out.
Cegedim has received a firm purchase offer for said division from IMS Health Inc. for an amount in cash of €385 million.
This offer includes the transfer of all business activities of theexcept from departments that provide sales data in the EU, such as GERS France and Pharmastock.
Said transaction, if it is accepted, will enable Cegedim to refocus on software and data bases for health professionals and health insurance companies, as well as on its multi-industrial strong group activities, such as e-business, e-collaboration and outsourcing of pay and of human resources.
If accepted and following examination by the regulatory authorities, it should be finalized at the beginning of 2015.
Established in 1969, Cegedim is a leading world technologies and services company specialized in the health sector. The company has 8,000 employees in 80 countries and made sales of €902 million in 2013. Cegedim proposes services, IT tools, specialized software, flow management and data base services. Its offers are geared, in particular, to health industries, pharmaceutical laboratories, health professionals and insurance companies.
For said transaction, Cegedim was advised in connection with the carving out CMS Bureau Francis Lefebvre avec Laurent Hepp, Edouard Milhac, Charles de Crevoisier and Florian Burnat for tax aspects; Jean-Eric Cros and Marc Flamand for corporate aspects.
The other advisors of the transaction were:
Social Media cookies collect information about you sharing information from our website via social media tools, or analytics to understand your browsing between social media tools or our Social Media campaigns and our own websites. We do this to optimise the mix of channels to provide you with our content. Details concerning the tools in use are in our privacy policy.